Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("BLOQUANT BETA -ADRENERGIQUE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 7092

  • Page / 284

Export

Selection :

  • and

ANESTHETIC MANAGEMENT PROBLEMS POSED BY THERAPEUTIC ADVANCES. III. BETA-ADRENERGIC BLOCKING DRUGS = PROBLEMES DE LA CONDUITE DE L'ANESTHESIE POSES PAR LES PROGRES THERAPEUTIQUES. III. AGENTS BLOQUANT LES RECEPTEURS BETA -ADRENERGIQUES1972; ANESTH. AND ANALG.; U.S.A.; DA. 1972; VOL. 51; NO 4; PP. 617-623; BIBL. 1 P. 1/2Serial Issue

INDENOLOL IN HYPERTENSIONSEGA R; MAILLAND F; DAMIANI E et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 289-293; BIBL. 11 REF.Article

ABSOLUTE CONFIGURATION BY ASYMMETRIC SYNTHESIS OF (+)-1-(4-ACETAMIDOPHENOXY)-3-(ISOPROPYLAMINO)-PROPAN-2-OL (PRACTOLOL)DANILEWICZ JC; KEMP JEG.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 2; PP. 168-169; BIBL. 4REF.Serial Issue

2.124.560 (B) (7204138). - 8 FEVRIER 1972. NOUVEAUX DERIVES D'ALCANOLAMINES DOUES D'ACTIVITE PHARMACOLOGIQUE ET LEUR PROCEDE DE PREPARATIONsdPatent

PROBLEMS WITH PRACTOLOL.WAAL MANNING HJ.1975; DRUGS; SWITZ.; DA. 1975; VOL. 10; NO 5-6; PP. 336-341; BIBL. 32 REF.Article

A PROPOS D'UN NOUVEL BETA-BLOQUANT LB 46-VISKENOULHACI M; MERAD B; TOUMI N et al.1973; TUNISIE MED.; TUNISIE; DA. 1973; NO 6; PP. 369-373Article

2.133.982 (B) (72 14059). - 20 AVRIL 1972. DERIVES DE BENZOFURANEsdPatent

ZUR PHARMAKOLOGIE VON ( +OU- )-1-(4-CYCLOHEXYLUREIDOPHENOXY)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115). = PHARMACOLOGIE DU ( +OU- )-1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYL-AMINO PROPANE (TALINOLOL, CORDANUM, 02-115)FEMMER K; BARTSCH R; LEONHARDT U et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 642-651; BIBL. 36 REF.Article

HOW DANGEROUS IN PROPRANOLOL. = QUEL EST LE DANGER DU PROPRANOLOL.ERIKSSEN J; GREENBLATT DJ; KOCH WESER J et al.1974; AMER. HEART J.; U.S.A.; DA. 1974; VOL. 88; NO 3; PP. 391; BIBL. 2REF.Article

A NEW CARDIOSELECTIVE BETA -ADRENOCEPTOR BLOCKING AGENTWOOLDRIDGE KRH.1972; EXPERIENTIA; SUISSE; DA. 1972; VOL. 28; NO 12; PP. 1404; ABS. ALLEM.; BIBL. 7 REF.Serial Issue

2.108.098 (B) (7134984). - 29SEPTEMBRE1971. NOUVEAUX DERIVES DE L'INDOLE, LEUR PREPARATION ET MEDICAMENTS LES CONTENANTsdPatent

2.108.099 (B) (7134985). - 29SEPTEMBRE1971. NOUVEAUX DERIVES DE L'INDOLE, LEUR PREPARATION ET MEDICAMENTS CONTENANT CES DERIVESsdPatent

2.121.447 (A) (7101113). - 14 JANVIER 1971. ARYLOXYALCOYLAMINES, LEUR PREPARATION ET LEUR APPLICATIONsdPatent

2.121.607 (B) (7200271). - 6JANVIER 1971. NOUVEAUX DERIVES DE L'INDOLE, LEUR PREPARATION ET MEDICAMENTS CONTENANT CES DERIVESsdPatent

CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING DRUGS. XIII: THE BETA-ADRENOCEPTOR BLOCKING DRUGS: A PERSPECTIVEFRISHMAN W.1980; AMER. HEART J.; USA; DA. 1980; VOL. 99; NO 5; PP. 665-670; BIBL. 104 REF.Article

UTILISATION DES BETAS-BLOQUANTS DANS LE DECLENCHEMENT DU TRAVAILURBAN J.1972; GINEKOL. POLSKA; POLSKA; DA. 1972; VOL. 43; NO 7; PP. 829-832; ABS. RUSSE ANGL.; BIBL. 6 REF.Article

GLUCOSE AND LIPID METABOLISM DURING ACEBUTOLOL AND PROPRANOLOL THERAPY OF ANGINA IN NONDIABETIC PATIENTSBIRNBAUM J; DIBIANCO R; BECKER KL et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 294-300; BIBL. 66 REF.Article

PHARMACOKINETICS OF THE BETA -ADRENERGIC BLOCKER SOTALOL IN DOGSSCHNELLE K; GARRETT ER.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 3; PP. 362-375; BIBL. 19 REF.Serial Issue

SYNTHESE DE NOUVEAUX DERIVES DE L'INDENE A PROPRIETES BETA -BLOQUANTES ADRENERGIQUESMURASE K; NIIGATA K; MASE T et al.1972; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JAP.; DA. 1972; VOL. 92; NO 11; PP. 1358-1363; ABS. ANGL.; BIBL. 5 REF.Serial Issue

WAS IST GESICHERT IN DER BEHANDLUNG MIT BETA -RECEPTORENBLOCKERN. = QU'Y A-T-IL DE SUR DANS LE TRAITEMENT PAR LES BLOQUANTS BETA -ADRENERGIQUES.EGIDY HV.1972; INTERNIST; DTSCH.; DA. 1972; VOL. 13; NO 12; PP. 481-484; BIBL. 16REF.Serial Issue

2.137.587 (B) (7216237). - 5MAI 1972. DERIVES DU BENZENEsdPatent

INDICATIONS ET CHOIX DES BETA-BLOQUANTS EN ENDOCRINOLOGIEPROUST B; HOUDENT C; BALACHEFF O et al.1982; REV. FR. ENDOCRINOL. CLIN., NUTR. METAB.; ISSN 0048-8062; FRA; DA. 1982; VOL. 23; NO 1; PP. 63-69; ABS. ENG; BIBL. 37 REF.Article

CARDIO-SELECTIVE BETA -ADRENERGIC BLOCKING AGENTS.SMITH LH.1978; J. APPL. CHEM. BIOTECHNOL.; G.B.; DA. 1978; VOL. 28; NO 3; PP. 201-212; BIBL. 16 REF.Article

ERYTHROPOIETIN PRODUCTION AFTER RENAL DENERVATION OR BETA-ADRENERGIC BLOCKADEFINK GD; FISHER JW.1976; AMER. J. PHYSIOL.; U.S.A.; DA. 1976; VOL. 230; NO 2; PP. 508-513; BIBL. 22 REF.Article

MODIFICATION OF STIMULATED LACRIMAL GLAND FLOW BY SYMPATHETIC NERVE IMPULSES IN RABBITBOTELHO SY; MARTINEZ EV; PHOLPRAMOOL C et al.1976; AMER. J. PHYSIOL.; U.S.A.; DA. 1976; VOL. 230; NO 1; PP. 80-84; BIBL. 30 REF.Article

  • Page / 284